|
MSI's London accounting firm member haysmacintyre is acts as reporting accountants for Medgenics Inc., a US based company with key operations in Israel.
The firm acted for Medgenics as they raised £3.28 million in their Initial Public Offering in conjunction with their listing on AIM in December 2007.
Medgenics Inc, a US based company with a wholly owned subsidiary in Israel, is a biopharmaceutical company developing a unique, tissue-based “Biopump” platform technology to provide sustained action protein therapy for the treatment for a range of chronic diseases.
haysmacintyre partner, Ian Cliffe, believes the firm was appointed due to its experience and expertise in acting as reporting accountants for overseas entities.
Members and clients will be pleased to learn that due to the increase in international companies listing on AIM*, haysmacintyre has launched an “introduction to AIM” pack.
These packs can be distributed to clients with an interest in raising finance in the UK. If your firm would like a complimentary pack or host a workshop for its clients on AIM, please contact David Cox (dcox@haysmacintyre.com) at haysmacintyre for support materials and access to speakers.
* The total market capitalisation of the 31 non-UK stocks that floated on the alternative investment market (AIM) in the fourth quarter of 2007 totalled £1.9bn ($3.8bn) compared with £1.7bn for UK listings. Source: Financial Times & LSE.
|